La radioterapia adiuvante nel carcinoma mammario: Timing e ruolo della IORT

Translated title of the contribution: Adjuvant radiotherapy of breast cancer: Timing and rôle of IORT

Research output: Contribution to journalArticle

Abstract

Adjuvant radiotherapy as a standard procedure after conservative surgery on the breast is a subject of discussion by many authors. Based on the radionale that most disease recurrences are observed in the quadrant of the primary tumour, many studies have been conducted and others are still ongoing to evaluate the efficacy of a partial irradiation of the mammary gland with the use of interstitial brachytherapy or external beams of electrons or photons, also with sophisticated techniques (conformational 3-D radiotherapy or IMRT). At the European Institute of Oncology (EIO), it has been decided to use intraoperative radiotherapy (IORT), and a mobile, miniaturized accelerator, delivering electron beams directly on the residual mammary gland during surgery, has been set up in an operating room. The experience of the EIO has been drawn from a phase I study (dose escalation) and a phase II study (to evaluate acute and middle-term toxicity); finally a phase III study has been started, and is still ongoing, to compare the efficacy of partial irradiation by IORT with respect to conventional radiotherapy on the whole breast. The toxicity so far detected is absolutely acceptable, but is necessary to wait for the end of the study in order to have the preliminary data, and for an adequate period of follow-up in order to evaluate the results.

Original languageItalian
Pages (from-to)191-193
Number of pages3
JournalEuropean Journal of Oncology
Volume8
Issue number3
Publication statusPublished - Sep 2003

Fingerprint

Adjuvant Radiotherapy
Radiotherapy
Breast Neoplasms
Human Mammary Glands
Breast
Electrons
Brachytherapy
Operating Rooms
Photons
Recurrence
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

La radioterapia adiuvante nel carcinoma mammario : Timing e ruolo della IORT. / Leonardi, Maria Cristina; Lazzari, Roberta; Catalano, Giampiero; Ciocca, Mario; Cattani, Federica; Rondi, Elena; Garibaldi, Cristina; Tosi, Giampiero; Orecchia, Roberto.

In: European Journal of Oncology, Vol. 8, No. 3, 09.2003, p. 191-193.

Research output: Contribution to journalArticle

@article{fa43cf74fe2348b79acd00675416de4a,
title = "La radioterapia adiuvante nel carcinoma mammario: Timing e ruolo della IORT",
abstract = "Adjuvant radiotherapy as a standard procedure after conservative surgery on the breast is a subject of discussion by many authors. Based on the radionale that most disease recurrences are observed in the quadrant of the primary tumour, many studies have been conducted and others are still ongoing to evaluate the efficacy of a partial irradiation of the mammary gland with the use of interstitial brachytherapy or external beams of electrons or photons, also with sophisticated techniques (conformational 3-D radiotherapy or IMRT). At the European Institute of Oncology (EIO), it has been decided to use intraoperative radiotherapy (IORT), and a mobile, miniaturized accelerator, delivering electron beams directly on the residual mammary gland during surgery, has been set up in an operating room. The experience of the EIO has been drawn from a phase I study (dose escalation) and a phase II study (to evaluate acute and middle-term toxicity); finally a phase III study has been started, and is still ongoing, to compare the efficacy of partial irradiation by IORT with respect to conventional radiotherapy on the whole breast. The toxicity so far detected is absolutely acceptable, but is necessary to wait for the end of the study in order to have the preliminary data, and for an adequate period of follow-up in order to evaluate the results.",
keywords = "Adjuvant radiotherapy, Breast cancer, Intraoperative radiotherapy",
author = "Leonardi, {Maria Cristina} and Roberta Lazzari and Giampiero Catalano and Mario Ciocca and Federica Cattani and Elena Rondi and Cristina Garibaldi and Giampiero Tosi and Roberto Orecchia",
year = "2003",
month = "9",
language = "Italian",
volume = "8",
pages = "191--193",
journal = "European Journal of Oncology",
issn = "1128-6598",
publisher = "Mattioli 1885 S.p.A.",
number = "3",

}

TY - JOUR

T1 - La radioterapia adiuvante nel carcinoma mammario

T2 - Timing e ruolo della IORT

AU - Leonardi, Maria Cristina

AU - Lazzari, Roberta

AU - Catalano, Giampiero

AU - Ciocca, Mario

AU - Cattani, Federica

AU - Rondi, Elena

AU - Garibaldi, Cristina

AU - Tosi, Giampiero

AU - Orecchia, Roberto

PY - 2003/9

Y1 - 2003/9

N2 - Adjuvant radiotherapy as a standard procedure after conservative surgery on the breast is a subject of discussion by many authors. Based on the radionale that most disease recurrences are observed in the quadrant of the primary tumour, many studies have been conducted and others are still ongoing to evaluate the efficacy of a partial irradiation of the mammary gland with the use of interstitial brachytherapy or external beams of electrons or photons, also with sophisticated techniques (conformational 3-D radiotherapy or IMRT). At the European Institute of Oncology (EIO), it has been decided to use intraoperative radiotherapy (IORT), and a mobile, miniaturized accelerator, delivering electron beams directly on the residual mammary gland during surgery, has been set up in an operating room. The experience of the EIO has been drawn from a phase I study (dose escalation) and a phase II study (to evaluate acute and middle-term toxicity); finally a phase III study has been started, and is still ongoing, to compare the efficacy of partial irradiation by IORT with respect to conventional radiotherapy on the whole breast. The toxicity so far detected is absolutely acceptable, but is necessary to wait for the end of the study in order to have the preliminary data, and for an adequate period of follow-up in order to evaluate the results.

AB - Adjuvant radiotherapy as a standard procedure after conservative surgery on the breast is a subject of discussion by many authors. Based on the radionale that most disease recurrences are observed in the quadrant of the primary tumour, many studies have been conducted and others are still ongoing to evaluate the efficacy of a partial irradiation of the mammary gland with the use of interstitial brachytherapy or external beams of electrons or photons, also with sophisticated techniques (conformational 3-D radiotherapy or IMRT). At the European Institute of Oncology (EIO), it has been decided to use intraoperative radiotherapy (IORT), and a mobile, miniaturized accelerator, delivering electron beams directly on the residual mammary gland during surgery, has been set up in an operating room. The experience of the EIO has been drawn from a phase I study (dose escalation) and a phase II study (to evaluate acute and middle-term toxicity); finally a phase III study has been started, and is still ongoing, to compare the efficacy of partial irradiation by IORT with respect to conventional radiotherapy on the whole breast. The toxicity so far detected is absolutely acceptable, but is necessary to wait for the end of the study in order to have the preliminary data, and for an adequate period of follow-up in order to evaluate the results.

KW - Adjuvant radiotherapy

KW - Breast cancer

KW - Intraoperative radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0242354161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242354161&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0242354161

VL - 8

SP - 191

EP - 193

JO - European Journal of Oncology

JF - European Journal of Oncology

SN - 1128-6598

IS - 3

ER -